It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
COVID-19 Rapid Evidence Reviews
Toggle navigation
New Search
SK Repository
About
Help
Your Cart:
0
items
Refine Search
Refine Search
Revise search
Search
Document Type
Apply
Evidence Search Report
14
Rapid Review
13
Table
Research Team
Apply
EOC
8
Epidemiology & Modelling
1
Infectious Disease
1
Status
Apply
5. Updated review
3
3. Completed
7
Category
Apply
Administration
1
Clinical Management
3
Clinical Presentation
3
Epidemiology
1
Healthcare Services
4
Infection Prevention and Control
4
Subject
Apply
Antigens
1
Asymptomatic
1
Cancer
1
Chemotherapy
1
Clinical Presentation
6
Comorbidities
Critical Care
1
Decision Making
7
Health Planning
10
Hospitalization
1
Immunity
4
Infection Prevention and Control
10
More
Population
Apply
All
Other
vulnerable populations (clinically)
1
Clinical Setting
Apply
Acute Care
1
Cardiac unit
1
Community
4
Dialysis unit
1
ICU
2
Long Term Care
1
Medicine Unit
2
NICU
1
Oncology
1
Other
1
Primary care
5
Public Health
5
More
Advanced Search
All Records
Other
Indigenous Peoples
All
Comorbidities
Vaccines
Table
Sorted by
Research Question / Title
Sort by Relevance
Sort by Newest
Sort by Oldest
Table View
List View
Citation View
Expand all
Collapse all
Select All
10 records – page 1 of 1.
Prev
Next
Date
Research Question / Title
Unique ID
Research Team
December 26, 2021
How effective are COVID-19 vaccines?
INF031801v019 RR Table
Infectious Disease
May 19, 2020
Risk estimates for clinical factors predicting severity and/ or mortality associated with COVID-19
EPM050901 RR Table
Epidemiology & Modelling
August 24, 2021
What are other jurisdictions offering for incentive-based COVID-19 vaccine campaigns?
EOC210501v2 RR Table
EOC
January 22, 2021
What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update]
EOC062201v2 RR Table
EOC
February 4, 2022
What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines?
EOC220103 RR Table
EOC
April 21, 2021
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
EOC210302 RR Table
EOC
June 7, 0222
What is the efficacy of a 4th booster dose for COVID-19?
EOC220304v002 RR Table
EOC
May 27, 2022
What is the evidence on timing and outcomes of elective surgery after a COVID infection?
EOC220504 RR Table
EOC
March 10, 2022
What is the safety/efficacy of the Novavax COVID-19 vaccine?
EOC220302 RR Table
EOC
May 24, 2022
When should post-COVID infected patients receive booster shots?
EOC220503 RR Table
EOC
10 records – page 1 of 1.
Prev
Next